Primary Care

In this Consultant360 interview, Brian Bergmark, MD explains how olezarsen, an RNA-targeted therapy targeting APOC3, may help address residual cardiovascular risk in patients with moderate...

Matthew B. Carroll, MD, MACP, FACR, discusses his ACP Internal Medicine Meeting presentation on four foot and ankle conditions frequently seen in primary care. He shares clinical considerations for initial...

At the 2025 AAPA meeting, Paul A. Coleman, DMSc, PA-C, DFAAPA, of Thomas Jefferson University, outlined a critical clinical challenge: distinguishing between hip and spine pathologies. With low back pain...

In this expert conversation, David S. Cooper MD, professor of medicine and radiology at the Johns Hopkins University School of Medicine, explores how antithyroid medications, particularly methimazole,...

In this interview, Deya N. Jourdy, MD, talks about the clinical features, prevalence, diagnosis, and treatment for nasal polyps, including what surgical options are available for patients.

In this interview, Elmar Joura, MD, answers questions about the long-term follow-up data on sustained immunogenicity and safety for the 9-valent human papillomavirus (HPV) vaccine, including indications,...

In this interview, Jacob C. Jentzer, MD, assistant professor of medicine in the Department of Cardiovascular Medicine at the Mayo Clinic in Rochester, Minnesota discusses the implications of his study and...

Steven E. Nissen, MD, lead author of the study “Bempedoic Acid And Cardiovascular Outcomes In Statin-Intolerant Patients,” answers questions on the importance of his team’s research on bempedoic acid, how...

Researchers found that despite eligibility, few adults with type 2 diabetes use GLP-1 receptor agonists and SGLT-2 inhibitors. The study’s lead investigator Shichao Tang, PhD, answers questions about the...

In this Q&A, W. Clay Jackson, MD, DipTH, speaks about various aspects of schizophrenia, including the symptoms, risk factors, and associated controversies surrounding these risk factors.